David Spellman
Overview
David Spellman received $2M in total compensation, including $299K in salary, at Mersana Therapeutics in 2018.
Source: SEC filing on April 23, 2019.
Related executives
We found 11 more executives who work or worked at Mersana Therapeutics.
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
Martin Huber
Mersana Therapeutics
Chief Executive Officer
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
Mohan Bala
Mersana Therapeutics
Senior Vice President, Chief Development Officer
Michael Kaufman
Mersana Therapeutics